HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$101.68
Tradestie Score
51
Market Cap
$8.77B
P/E Ratio
25.7
Revenue Growth
0.4%
Analyst Upside
+17.9%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NBIX
Neurocrine Biosciences Inc
|
$174.41
|
$13.59B | 25.1 | 23 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$259.28
|
$12.36B | 19.7 | 34 | Compare |
|
EXEL
Exelixis Inc
|
$70.70
|
$11.09B | 21.1 | 23 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.85
|
$10.76B | - | 42 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$248.69
|
$10.74B | - | 34 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.33
|
$10.53B | - | 56 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.33
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.54
|
$10.22B | - | 33 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$433.03
|
$10.01B | - | 56 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.80
|
$9.33B | 66.8 | 52 | Compare |
More HALO Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry